Experienced in IgG4-Related Disease

Dr. Martha M. Tarpay

Allergy and Immunology
4200 W Memorial Rd, 
Okalhoma City, OK 
Clinical Trials:Currently Recruiting for 2 Trials
Accepting New Patients
Offers Telehealth

Experienced in IgG4-Related Disease
4200 W Memorial Rd, 
Okalhoma City, OK 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Martha Tarpay is an Allergy and Immunologist in Okalhoma City, Oklahoma. Dr. Tarpay is rated as an Experienced provider by MediFind in the treatment of IgG4-Related Disease. Her top areas of expertise are Bloom Syndrome, Urticaria Pigmentosa, Primary Immunodeficiency (PID), and Angioedema. Dr. Tarpay is currently accepting new patients.

Her clinical research consists of co-authoring 1 peer reviewed article and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Allergy and Immunology
Licenses
Allergy & Immunology in OK
Hospital Affiliations
Mercy Hospital Oklahoma City, Inc
Languages Spoken
English
Hungarian
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Dean Health
  • EPO
  • HMO
  • POS
  • PPO
GlobalHealth
  • INSURANCE PLAN
  • MEDICARE MAPD
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
TeamCare
  • OTHER COMMERCIAL
Trustmark
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 14 Less Insurance Carriers -

Locations

4200 W Memorial Rd, Okalhoma City, OK 73120
Call: 405-752-0393

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


7 Clinical Trials

16-Week Randomized Double-Blind Placebo Controlled Parallel-Group Multicenter Study Evaluating the Efficacy and Safety of OPN-375 186 μg Twice a Day in Adolescents With Bilateral Nasal Polyps Followed With 12-Week Open-Label Treatment Phase
16-Week Randomized Double-Blind Placebo Controlled Parallel-Group Multicenter Study Evaluating the Efficacy and Safety of OPN-375 186 μg Twice a Day in Adolescents With Bilateral Nasal Polyps Followed With 12-Week Open-Label Treatment Phase
Enrollment Status: Recruiting
Publish Date: September 29, 2025
Intervention Type: Drug
Study Drug: OPN-375
Study Phase: Phase 3
A Longitudinal Observational Study of Patients Undergoing Therapy for Immune-Mediated Inflammatory Skin Conditions
A Longitudinal Observational Study of Patients Undergoing Therapy for Immune-Mediated Inflammatory Skin Conditions
Enrollment Status: Recruiting
Publish Date: May 04, 2025
A Randomised, Double-blind, Parallel Group Phase III Study to Assess the Efficacy and Safety of 100 mg SC Depemokimab in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) - ANCHOR-2 (depemokimAb iN CHrOnic Rhinosinusitis)
A Randomised, Double-blind, Parallel Group Phase III Study to Assess the Efficacy and Safety of 100 mg SC Depemokimab in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) - ANCHOR-2 (depemokimAb iN CHrOnic Rhinosinusitis)
Enrollment Status: Completed
Publish Date: September 09, 2025
Intervention Type: Biological, Drug
Study Phase: Phase 3
A Randomised, Double-blind, Parallel Group, Multicentre, Stratified, Study Evaluating the Efficacy and Safety of Once Daily Fluticasone Furoate/Vilanterol Inhalation Powder Compared to Once Daily Fluticasone Furoate Inhalation Powder in the Treatment of Asthma in Participants Aged 5 to 17 Years Old (Inclusive) Currently Uncontrolled on Inhaled Corticosteroids
A Randomised, Double-blind, Parallel Group, Multicentre, Stratified, Study Evaluating the Efficacy and Safety of Once Daily Fluticasone Furoate/Vilanterol Inhalation Powder Compared to Once Daily Fluticasone Furoate Inhalation Powder in the Treatment of Asthma in Participants Aged 5 to 17 Years Old (Inclusive) Currently Uncontrolled on Inhaled Corticosteroids
Enrollment Status: Completed
Publish Date: June 22, 2025
Intervention Type: Drug
Study Drugs: Fluticasone Furoate, Vilanterol
Study Phase: Phase 3
A Multi-center, Single-Sequence, Open-label Study to Evaluate IGSC 20% Biweekly Dosing in Treatment-Experienced Subjects and Loading/Maintenance Dosing in Treatment-Naïve Subjects With Primary Immunodeficiency
A Multi-center, Single-Sequence, Open-label Study to Evaluate IGSC 20% Biweekly Dosing in Treatment-Experienced Subjects and Loading/Maintenance Dosing in Treatment-Naïve Subjects With Primary Immunodeficiency
Enrollment Status: Completed
Publish Date: September 29, 2023
Intervention Type: Biological
Study Phase: Phase 4
Hypoallergenicity Evaluation of a New Extensively Hydrolyzed Formula
Hypoallergenicity Evaluation of a New Extensively Hydrolyzed Formula
Enrollment Status: Completed
Publish Date: January 30, 2019
Intervention Type: Other
Study Phase: Not Applicable
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Enrollment Status: Completed
Publish Date: June 08, 2017
Intervention Type: Other
Study Phase: Not Applicable
View 5 Less Clinical Trials

1 Total Publications

The effect of GSK2190915, a 5-lipoxygenase-activating protein inhibitor, on exercise-induced bronchoconstriction.
The effect of GSK2190915, a 5-lipoxygenase-activating protein inhibitor, on exercise-induced bronchoconstriction.
Journal: Allergy and asthma proceedings
Published: April 11, 2014
Similar Doctors
Tim D. Trojan
Experienced in IgG4-Related Disease
Dr. Tim D. Trojan
Allergy and Immunology
Experienced in IgG4-Related Disease
Dr. Tim D. Trojan
Allergy and Immunology

Allergy Partners Of Oklahoma - Enid

3201 North Van Buren Street, 
Enid, OK 
 (59.1 miles away)
580-366-0844
Languages Spoken:
English
See accepted insurances

Tim Trojan is an Allergy and Immunologist in Enid, Oklahoma. Dr. Trojan is rated as a Distinguished provider by MediFind in the treatment of IgG4-Related Disease. His top areas of expertise are Grass Allergy, Sinusitis, Allergic Rhinitis, and Hives.

VIEW MORE IGG4-RELATED DISEASE DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Tarpay's expertise for a condition
ConditionClose
      • Advanced
      • Angioedema
        Dr. Tarpay is
        Advanced
        . Learn about Angioedema.
        See more Angioedema experts
      • Bloom Syndrome
        Dr. Tarpay is
        Advanced
        . Learn about Bloom Syndrome.
        See more Bloom Syndrome experts
      • Primary Immunodeficiency (PID)
        Dr. Tarpay is
        Advanced
        . Learn about Primary Immunodeficiency (PID).
        See more Primary Immunodeficiency (PID) experts
      • Urticaria Pigmentosa
        Dr. Tarpay is
        Advanced
        . Learn about Urticaria Pigmentosa.
        See more Urticaria Pigmentosa experts
      • Experienced
      • Allergic Conjunctivitis
        Dr. Tarpay is
        Experienced
        . Learn about Allergic Conjunctivitis.
        See more Allergic Conjunctivitis experts
      • Allergic Rhinitis
        Dr. Tarpay is
        Experienced
        . Learn about Allergic Rhinitis.
        See more Allergic Rhinitis experts
      • Anaphylaxis
        Dr. Tarpay is
        Experienced
        . Learn about Anaphylaxis.
        See more Anaphylaxis experts
      • Asthma
        Dr. Tarpay is
        Experienced
        . Learn about Asthma.
        See more Asthma experts
      • Chronic Cough
        Dr. Tarpay is
        Experienced
        . Learn about Chronic Cough.
        See more Chronic Cough experts
      • Common Variable Immune Deficiency
        Dr. Tarpay is
        Experienced
        . Learn about Common Variable Immune Deficiency.
        See more Common Variable Immune Deficiency experts
      View All 18 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile
      For Patients
      • Our Story
      • How MediFind Works
      • Conditions A-Z
      • Doctor Directory
      • Symptoms Directory
      • Procedures Directory
      • Treatment Directory
      • Drug Directory
      • Infusion Center Finder
      • FAQ
      • Contact Us
      For Providers and Practices
      • Claim Your Profile
      • Newsroom
      Business Solutions
      • Provider
      • Network Solutions
      Additional Resources
      • Consumer Health Data Privacy Policy
      • Privacy Policy
      • Terms of Use
      • Advertising Policy
      • Content Policy
      Subscribe to our newsletter

      Sign up to stay informed about MediFind and get wellness sent your way.

      Close

        By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

        Bullet PinMediFind
        Follow us on
        This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
        © 2025 All Rights Reserved